Oklahoma City, OK Market Overview
4/17/2013 | published by: HealthLeaders InterStudy
... health systems are piloting medical homes and bundled payments and expanding services. This year, Oklahoma City will become one of the few markets to offer two proton therapy treatment centers, making it a medical tourism ...
|
read more...
|
$1,665.00
|
Herbal/Traditional Products in Greece
4/17/2013 | published by: Euromonitor International
... Thus, herbal/traditional products in Greece seem to be caught between two opposing developments. On the one hand, the current health and wellness trend, which is evident across a wide range of fmcg industries including packaged ...
|
read more...
|
$900.00
|
Spain Pharmaceuticals and Healthcare Report Q2 2013
4/17/2013 | published by: Business Monitor International
... fordrugmakers selling their products in Spain. The success of the implemented policies may encourage theenforcement of further cost-containment measures, which, with the ongoing public hospital debt situation,seriously hampers the country's attractiveness as a location in ...
|
read more...
|
$1,175.00
|
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2013
4/17/2013 | published by: Business Monitor International
... 2012 to LKR68.50bn (US$540mn) in 2013; +14.4% in local currency terms and +15.2% in US dollar terms. Healthcare: LKR250.92bn (US$1.97bn) in 2012 to LKR281.13bn (US$2.22bn) in 2013; +12.0% inlocal currency terms and 12.7% in US ...
|
read more...
|
$1,175.00
|
Jordan Pharmaceuticals and Healthcare Report Q2 2013
4/17/2013 | published by: Business Monitor International
... to the growing population, increased urbanisation and incidence of noncommunicablediseases as well as swifter uptake of drugs. However, the biggest downside risk toinvestment is the country's relatively young population and lack of jobs, which will ...
|
read more...
|
$1,175.00
|
Iran Pharmaceuticals and Healthcare Report Q2 2013
4/17/2013 | published by: Business Monitor International
... supply is on the verge of complete depletion, webelieve the Iranian government will be placed in an extremely difficult position either needing to makeconcessions to its nuclear programme to avoid a complete economic collapse, or ...
|
read more...
|
$1,175.00
|
Peru Pharmaceuticals and Healthcare Report Q2 2013
4/17/2013 | published by: Business Monitor International
... using Peru as a production hub to export to neighbouring countries. The strict regulatorystandards in Peru are also to the advantage of multinationals, which can leverage their industrialexpertise in production and reduce competition from local ...
|
read more...
|
$1,175.00
|
South Africa Pharmaceuticals and Healthcare Report Q2 2013
4/17/2013 | published by: Business Monitor International
... the Rand, should be seen as an opportunity for local drugmakers to shift focustowards increasing exports to emerging markets in order to drive long-term revenues. Although thegovernment favours local drugmakers in tender allocations, increasing generic ...
|
read more...
|
$1,175.00
|
|
|
$125.00
|
Iowa Health System - Strategic SWOT Analysis Review
4/16/2013 | published by: GlobalData
... 14 senior affiliate hospital locations, 11 community network hospitals and four accredited colleges of nursing and allied health fields. The organization’s entities offer patient care in Illinois and Iowa. Its entities also include four accredited ...
|
read more...
|
$125.00
|
Baylor Health Care System - Strategic SWOT Analysis Review
4/16/2013 | published by: GlobalData
... centers, rehabilitation clinics, senior care centers, day surgery centers, fitness and wellness centers, imaging centers, specialty care centers and the Baylor Research Institute. Baylor Health Care System Key Recent Developments Apr 09, 2013: Three Health ...
|
read more...
|
$125.00
|
Highmark Inc. - Strategic SWOT Analysis Review
4/16/2013 | published by: GlobalData
... provides health insurance, dental insurance, vision insurance and supplemental medicare products; and process claims for various medicare members. The company is an independent licensee of Blue Cross and Blue Shield Association. The company operates through ...
|
read more...
|
$125.00
|
|
|
$125.00
|
|
|
$500.00
|
|
|
$199.00
|
|
|
$199.00
|
Laboratory Information Management System Market in India 2013
4/12/2013 | published by: Netscribes (India) Pvt. Ltd.
... seeing rise in number of various types of laboratories will propel the future of LIMS adoption in Indian healthcare sector as well. Laboratory Information Management System Market in India 2013 begins with macro economic indicators ...
|
read more...
|
$850.00
|
Herbal/Traditional Products in Poland
4/11/2013 | published by: Euromonitor International
... and safe medicines often reach for herbal-based formulations, which are considered to offer fewer, if any, side effects. In addition, such products tend to bear lower prices than standard equivalents, a factor that proves appealing ...
|
read more...
|
$900.00
|
|
|
$149.00
|
2013 U.S. Ambulance Services Industry-Industry & Market Report
4/10/2013 | published by: Barnes Reports
... the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ratios, number of firms, payroll, industry definition, 5-year historical trends on industry sales, establishments ...
|
read more...
|
$149.00
|
Disease and Therapy Review: Kidney Transplant
4/10/2013 | published by: Timely Data Resources, Inc.
... included, with discussion of diagnosis and prognosis of kidney disease and transplant. Immunosuppressant treatment options are discussed, with dosing and treatment costs provided. Market size estimates and annual sales of leading therapies are also provided.
|
read more...
|
$950.00
|
|
|
$149.00
|
|
|
$149.00
|
Colombia Pharmaceuticals and Healthcare Report Q2 2013
4/10/2013 | published by: Business Monitor International
... high per capita spending on medicines. Nevertheless, growingpharmaceutical demand will remain a substantial draw for foreign drugmakers. Headline Expenditure Projections Pharmaceuticals: COP7,548bn (US$4.20bn) in 2012 to COP8,071bn (US$4.45bn) in 2013;+6.9% in local currency terms and ...
|
read more...
|
$1,175.00
|
Argentina Pharmaceuticals and Healthcare Report Q2 2013
4/10/2013 | published by: Business Monitor International
... potential currency devaluation in the future will increaseArgentina's export of medicines to a certain extent, if the country's structural distorting policies have noteroded its local pharmaceutical production capacity. Headline Expenditure Projections Pharmaceuticals: ARS39.4bn (US$8.7bn) in ...
|
read more...
|
$1,175.00
|